News for Healthier Living

Biomarkers Predict Patients with Glioblastoma Who Will Survive Longer After Treatment with Cancer-Targeting Virus

* Glioblastoma is a deadly brain cancer that suppresses the immune system and doesn't respond well to available therapies * Researchers engineered a cancer-targeting virus that can be injected directly in glioblastoma tumors * Adding an immune booster to the virus increased the length of survival in a subset of patients and helped identify blood biomarkers in patients most likely to benefit

February 11, 2026


February 15 2026

February 14 2026

February 13 2026

February 12 2026

February 11 2026

February 10 2026

February 9 2026

February 8 2026

February 7 2026

February 6 2026

February 5 2026

February 4 2026

February 3 2026

February 2 2026

February 1 2026